✦ LIBER ✦

PDB18 COST OFFSETS ASSOCIATED WITH USE OF EXENATIDE COMPARED TO GLARGINE FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES

✍ Scribed by MD Pawaskar; J Anderson; AJ Zagar

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB68 A RETROSPECTIVE ANALYSIS OF MEDICA

✍ MD Pawaskar; J Anderson; AJ Zagar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PDB23 THE IMPACT OF TREATMENT MODIFICATI

✍ M. Pawaskar; M. Bonafede; B.H. Johnson; R. Fowler; B.J. Hoogwerf 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PDB33 The Associated Costs of Treating T

✍ J. Langer; J.R. Bouchard 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PDB14 USING HEALTH OUTCOMES MODELING TO

✍ L. Garrison; J.H. Best; J.C. Robertson; M. Wenten; D. Bruhn 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

PDB27 COST-EFFECTIVENESS OF EXENATIDE VE

✍ D Bruhn; S Malhan; S Kavuncubasi; J Smith-Palmer; V Reed 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PDB18 THE RELATIVE COST EFFECTIVENESS OF

✍ P McEwan; N Mehin; AP Tetlow; P Sharplin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB